We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.72B
AUM Growth
+$377M
Cap. Flow
-$47.5M
Cap. Flow %
-0.83%
Top 10 Hldgs %
18.31%
Holding
1,615
New
130
Increased
604
Reduced
665
Closed
130

Sector Composition

Rank Sector Weight
1 Technology 19.17%
2 Financials 10.88%
3 Healthcare 10.31%
4 Consumer Discretionary 9.37%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUPH icon
1076
Aurinia Pharmaceuticals
AUPH
$1.91B
$457K 0.01%
20,000
+2,200
+12% +$52.1K
VT icon
1077
Vanguard Total World Stock ETF
VT
$77.2B
$456K 0.01%
4,246
+88
+2% +$9.35K
IGPT icon
1078
Invesco AI and Next Gen Software ETF
IGPT
$1.16B
$455K 0.01%
10,695
-669
-6% -$31.9K
LRCX icon
1079
Lam Research
LRCX
$368B
$455K 0.01%
6,330
-10,620
-63% -$666K
CDW icon
1080
CDW
CDW
$18.9B
$453K 0.01%
2,210
+28
+1% +$5.32K
SIEN
1081
DELISTED
Sientra, Inc.
SIEN
$453K 0.01%
12,340
+780
+7% +$37.8K
PACB icon
1082
Pacific Biosciences
PACB
$435M
$452K 0.01%
+22,125
New +$534K
BGB
1083
Blackstone Strategic Credit 2027 Term Fund
BGB
$500M
$450K 0.01%
33,352
+114
+0.3% +$1.58K
ALRM icon
1084
Alarm.com
ALRM
$2.71B
$449K 0.01%
5,291
-617
-10% -$50.5K
PSLV icon
1085
Sprott Physical Silver Trust
PSLV
$12B
$449K 0.01%
55,982
-2,678
-5% -$21.8K
THQ
1086
abrdn Healthcare Opportunities Fund
THQ
$779M
$449K 0.01%
17,485
-126
-0.7% -$3.03K
AZTA icon
1087
Azenta
AZTA
$1.3B
$445K 0.01%
4,311
-255
-6% -$27.6K
BGX
1088
Blackstone Long-Short Credit Income Fund
BGX
$136M
$445K 0.01%
30,272
+5,000
+20% +$75.4K
NICE icon
1089
Nice
NICE
$5.79B
$445K 0.01%
1,467
-43
-3% -$12.4K
TXT icon
1090
Textron
TXT
$14.7B
$445K 0.01%
5,765
+1,276
+28% +$94.7K
ASGI
1091
abrdn Global Infrastructure Income Fund
ASGI
$757M
$441K 0.01%
21,454
-355
-2% -$7.23K
ARKW icon
1092
ARK Web x.0 ETF
ARKW
$1.63B
$440K 0.01%
3,713
+327
+10% +$46.3K
TRHC
1093
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$439K 0.01%
29,279
-17,960
-38% -$327K
VLN icon
1094
Valens Semiconductor
VLN
$170M
$438K 0.01%
+56,875
New +$480K
NTAP icon
1095
NetApp
NTAP
$35.1B
$436K 0.01%
+4,741
New +$427K
MMP
1096
DELISTED
Magellan Midstream Partners, L.P.
MMP
$436K 0.01%
9,387
-531
-5% -$25.1K
LBRDK icon
1097
Liberty Broadband Class C
LBRDK
$4.89B
$432K 0.01%
2,684
-198
-7% -$32.6K
BETZ icon
1098
Roundhill Sports Betting & iGaming ETF
BETZ
$49.7M
$430K 0.01%
17,325
-1,139
-6% -$31.2K
IHE icon
1099
iShares US Pharmaceuticals ETF
IHE
$1.46B
$429K 0.01%
6,453
NMFC icon
1100
New Mountain Finance
NMFC
$651M
$429K 0.01%
31,288
+3,345
+12% +$45.7K

Similar funds

Oppenheimer & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Oppenheimer & Co held 1,615 positions worth $5.72B, up 7.1% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q4 2021 filing shows 130 new, 604 increased, 665 reduced and 130 closed positions. Its largest new stake was Invesco Total Return Bond ETF: 132,838 shares worth $7.49M. The largest sale was Global X S&P 500 Covered Call ETF, an estimated $49.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q4 2021 buy was Invesco Total Return Bond ETF: 132,838 shares worth $7.49M.
  • Oppenheimer & Co added most to Canadian Pacific Kansas City in Q4 2021, an estimated $7.48M increase.
  • Oppenheimer & Co's biggest Q4 2021 reduction was Global X S&P 500 Covered Call ETF, cutting an estimated $49.9M.
  • Oppenheimer & Co fully exited Kansas City Southern in Q4 2021, selling an estimated $6.61M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.72B portfolio in Q4 2021.
  • Oppenheimer & Co opened 130 new positions and closed 130 in Q4 2021.
  • Oppenheimer & Co's portfolio value rose 7.1% quarter-over-quarter to $5.72B.

Based on Oppenheimer & Co's 13F filing for Q4 2021, filed 2 Feb 2022.